Patent Applications published on Apr 24, 2025 - page 3

#601
US20250127669A1
Human necessities

LIFT FOR CHANGING THE POSITION OF THE SEAT IN A WHEELCHAIR

#602
US20250127670A1
Human necessities

PATIENT SUPPORT APPARATUSES WITH LOCKING FEATURES

#603
US20250127671A1
Human necessities

ISOLATION UNIT SYSTEMS AND METHODS

#604
US20250127672A1
Human necessities

CARE ENVIRONMENT VIDEO/AUDIO MONITORING SYSTEM

#605
US20250127673A1
Human necessities

HYPOMOCHLION OF AN OPERATING TABLE

#606
US20250127674A1
Human necessities

INTERFACE MOVEABLY INTERCONNECTING SURGICAL TABLE AND GANTRY

#607
US20250127675A1
Human necessities

UNDER-ACTUATED SOFT EXOSKELETON WITH CABLE ACTUATION SYSTEM FOR UPPER LIMB ASSISTANCE

#608
US20250127676A1
Human necessities

HOLDER FOR A WALKING FRAME

#609
US20250127677A1
Human necessities

TECHNOLOGY-ASSISTED WALKER FOR IMPROVING WALKER FUNCTIONALITY

#610
US20250127678A1
Human necessities

APPARATUS AND METHOD FOR PROVIDING VIRTUAL REALITY-BASED EYE MOVEMENT EXERCISE AND VISUAL PERCEPTION TRAINING

#611
US20250127679A1
Human necessities

Leg Massager

#612
US20250127680A1
Human necessities

PNEUMATIC THERAPY APPARATUS AND METHOD

#613
US20250127681A1
Human necessities

SOFT ACTUATOR AND MASSAGE DEVICE FOR VEHICLE SEAT

#614
US20250127682A1
Human necessities

CABIN FOR WELLNESS TREATMENTS, PARTICULARLY STEAM BATHS AND THE LIKE

#615
US20250127683A1
Human necessities

HEAT CONDUCTIVE NEEDLE FOR ACUPUNCTURE

#616
US20250127684A1
Human necessities

APPARATUS AND METHOD FOR HOLDING A VIAL

#617
US20250127685A1
Human necessities

DRUG POWDERIZATION WITHIN VIALS

#618
US20250127686A1
Human necessities

Manual Medicine Distributing Apparatus

#619
US20250127687A1
Human necessities

CONNECTORS FOR INFUSION PUMP FEEDING SETS

#620
US20250127688A1
Human necessities

Evolving pacifier

#621
US20250127689A1
Human necessities

METHOD OF STIMULATING DENTIN FORMATION WITH HYDROXY-SUBSTITUTED AZOBENZENE MATERIALS

#622
US20250127690A1
Human necessities

(METH)ACRYLAMIDE COMPOUND, MONOMER COMPOSITION, COMPOSITION FOR DENTAL MATERIAL, AND DENTAL MATERIAL

#623
US20250127691A1
Human necessities

EMULSIFIED COMPOSITION

#624
US20250127692A1
Human necessities

Liquid Makeup Compositions

#625
US20250127693A1
Human necessities

Materials for Desensitization and Targeted Drug Delivery to Teeth and Gums

#626
US20250127694A1
Human necessities

FRAGRANCE COMPOSITIONS AND USES THEREOF

#627
US20250127695A1
Human necessities

Use of Branched Medium-Chain Glycerol Ethers as Active Antidandruff Ingredients

#628
US20250127696A1
Human necessities

COMPOSITION FOR PREVENTING OR IMPROVING SKIN-AGING CONTAINING A THYMOL ESTER-BASED COMPOUND

#629
US20250127697A1
Human necessities

HAIR TREATMENT COMPOSITION WITH CATIONIC SURFACTANT, FATTY ALCOHOLS, AND LOW POLAR OIL

#630
US20250127698A1
Human necessities

Hair Perming Compositions With Amine Derivatives

#631
US20250127699A1
Human necessities

One Pot Process for Preparing 'Grit-Free' Solid Cleansing Compositions

#632
US20250127700A1
Human necessities

METHODS OF TREATING HYPERPIGMENTATION DISORDERS

#633
US20250127701A1
Human necessities

Cosmetical use of a topically applicable rinse-of composition (RC)

#634
US20250127702A1
Human necessities

SUNSCREEN COMPOSITION WITH CRYSTALLINE ORGANIC SUNSCREEN FILTERS

#635
US20250127703A1
Human necessities

LIPSTICK

#636
US20250127704A1
Human necessities

TYPE II UNMODIFIED CELLULOSE FINE FIBER AND MANUFACTURING METHODS FOR TYPE II UNMODIFIED CELLULOSE FINE FIBER AND MOLDED BODY OF THE SAME

#637
US20250127705A1
Human necessities

COSMETIC COMPOSITIONS COMPRISING A CYCLODEXTRIN HAVING A PARTICLE SIZE DISTRIBUTION

#638
US20250127706A1
Human necessities

COSMETIC COMPOSITION COMPRISING A POLYHYDROXYALKANOATE COPOLYMER BEARING A(N) (UN)SATURATED HYDROCARBON-BASED CHAIN AND A POLYSACCHARIDE

#639
US20250127707A1
Human necessities

FRAGRANCE FORMULATION

#640
US20250127708A1
Human necessities

COSMETIC COMPOSITION

#641
US20250127709A1
Human necessities

COSMETIC COMPOSITION CONTAINING IRIS GERMANICA ROOT-DERIVED EXOSOMES AS AN ACTIVE INGREDIENT

#642
US20250127710A1
Human necessities

CONTROLLED DRUG RELEASE PREPARATION COMPOSITION AND CONTROLLED DRUG RELEASE PREPARATION

#643
US20250127711A1
Human necessities

COMPOSITION AND METHOD FOR TREATING FUNGAL SKIN CONDITIONS AND INFLAMMATION

#644
US20250127712A1
Human necessities

COMPOSITIONS AND METHODS FOR THE TREATMENT OF OPIOID OVERDOSE

#645
US20250127713A1
Human necessities

LIQUID DEPOT FOR NON-INVASIVE SUSTAINED DELIVERY OF AGENTS TO THE EYE

#646
US20250127714A1
Human necessities

ORAL COMPOSITION OF CELECOXIB FOR TREATMENT OF PAIN

#647
US20250127715A1
Human necessities

ABUSE DETERRENT MORPHINE SULFATE DOSAGE FORMS

#648
US20250127716A1
Human necessities

INHALED IMATINIB FOR TREATMENT OF PULMONARY HYPERTENSION

#649
US20250127717A1
Human necessities

COMPOSITIONS AND METHODS OF MAKING BRITTLE-MATRIX PARTICLES THROUGH BLISTER PACK FREEZING

#650
US20250127718A1
Human necessities

TOPICAL FORMULATIONS FOR TREATING DERMATOLOGICAL DISORDERS INCLUDING MALE PATTERN BALDNESS

#651
US20250127719A1
Human necessities

ANISAMIDE-CONTAINING LIPIDS AND COMPOSITIONS AND METHODS OF USE THEREOF

#652
US20250127720A1
Human necessities

IONIZABLE LIPID NANOPARTICLES FOR IN UTERO mRNA DELIVERY

#653
US20250127721A1
Human necessities

PARALLEL-TYPE MEMBRANE EMULSIFICATION METHOD AND DEVICE FOR PREPARING BIODEGRADABLE POLYMER MICROSPHERES AND INJECTION FORMULATION PREPARATION METHOD USING SAME

#654
US20250127722A1
Human necessities

SOLID ORAL DOSAGE FORM COMPRISING ANTIBODIES FOR SUSTAINED RELEASE IN THE LOWER GASTROINTESTINAL TRACT

#655
US20250127723A1
Human necessities

PHARMACEUTICAL COMPOSITION COMPRISING LARGE PHYSIOLOGICALLY ACTIVE SUBSTANCE AND EXCIPIENT

#656
US20250127724A1
Human necessities

SUSTAINED RELEASE DOSAGE FORMS FOR A JAK1 INHIBITOR

#657
US20250127725A1
Human necessities

MAGNESIUM OXIDE TABLETS

#658
US20250127726A1
Human necessities

ENGINEERED MIGRASOME, METHOD FOR PREPARING SAME, AND USES THEREOF

#659
US20250127727A1
Human necessities

IONIZABLE LIPIDS WITH BIOACTIVE MOTIFS

#660
US20250127728A1
Human necessities

Constrained Ionizable Cationic Lipids and Lipid Nanoparticles

#661
US20250127729A1
Human necessities

PATCH FOR TARGETED DELIVERY OF AN ONCOGENIC CARGO TO A TISSUE

#662
US20250127730A1
Human necessities

METHODS OF PERMEABILIZING THE BLOOD BRAIN BARRIER

#663
US20250127731A1
Human necessities

COMPOSITIONS COMPRISING CURCUMINOIDS FOR USE IN THE TREATMENT OF MUSCLE SORENESS

#664
US20250127732A1
Human necessities

DOSAGE FORMS AND METHODS FOR ENANTIOMERICALLY ENRICHED OR PURE BUPROPION

#665
US20250127733A1
Human necessities

TOXIC ALDEHYDE RELATED DISEASES AND TREATMENT

#666
US20250127734A1
Human necessities

ALZ-801 FOR USE IN TREATING A COVID-19 ASSOCIATED NEUROLOGICAL SYMPTOM

#667
US20250127735A1
Human necessities

NOVEL COMPOSITION COMPRISING N-ACETYLCYSTEINE FOR OVERCOMING THE ADVERSE EFFECTS OF A CHEMOTHERAPY

#668
US20250127736A1
Human necessities

BUTYRATE AND BETA-HYDROXYBUTYRATE COMPOSITIONS

#669
US20250127737A1
Human necessities

NOVEL NAPROXEN SODIUM PREPARATIONS FOR PARENTERAL ADMINISTRATION

#670
US20250127738A1
Human necessities

DECALCIFICATION COMPOSITION FOR TREATMENT AND/OR PREVENTION OF CARDIOVASCULAR DISEASE

#671
US20250127739A1
Human necessities

STABLE GABAPENTIN POWDER

#672
US20250127740A1
Human necessities

COMPOSITION CONTAINING 3-HYDROXYANTHRANILIC ACID AND COMPOUNDS THAT ALTER IRON HOMEOSTASIS AND METHOD OF ITS USE

#673
US20250127741A1
Human necessities

MEDICINAL COMPOSITION COMPRISING RIBOSE AND AMINO ACIDS

#674
US20250127742A1
Human necessities

METHODS FOR TREATING NEUROBLASTOMA

#675
US20250127743A1
Human necessities

USE OF BRANCHED CHAIN FATTY ACIDS (BCFAS) FOR THE TREATMENT OF INTESTINAL INFLAMMATION

#676
US20250127744A1
Human necessities

Combination therapy of omega-3, black cumin, manuka honey, Anise, Vitamin-D, Nutmeg in treating COVID-19

#677
US20250127745A1
Human necessities

NOVEL COMPOSITIONS FOR PROMOTING EYE HEALTH OF A COMPANION ANIMAL

#678
US20250127746A1
Human necessities

TOPICAL CONTACT SENSITIZERS TO TREAT CANCER

#679
US20250127747A1
Human necessities

Prodrugs of Fumarates and Their Use in Treating Various Diseases

#680
US20250127748A1
Human necessities

METHODS FOR THE TREATMENT OF MIGRAINE AND RELATED HEADACHE SYMPTOMS USING TRICAPRYLIN

#681
US20250127749A1
Human necessities

METHOD FOR TREATING METASTATIC PROSTATE CANCER

#682
US20250127750A1
Human necessities

ISOTHIOCYANATE FUNCTIONAL COMPOUNDS AUGMENTED WITH SECONDARY ANTINEOPLASTIC MEDICAMENTS AND ASSOCIATED METHODS FOR TREATING NEOPLASMS

#683
US20250127751A1
Human necessities

Traditional Chinese Medicine Compound Preparation for Tumors and Application thereof

#684
US20250127752A1
Human necessities

REDUCED REBOUND EFFECTS IN SUBJECTS TREATED FOR OVERWEIGHT OR OBESITY

#685
US20250127753A1
Human necessities

PHARMACEUTICAL APPLICATION OF DIMYRICETIN-YL-DISELENIDE IN TUMORS

#686
US20250127754A1
Human necessities

Pharmaceutical Application of Dimyricetin-yl-diselenide in Atherosclerosis

#687
US20250127755A1
Human necessities

PHARMACOLOGICAL DEPLETION OF HEME FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROME

#688
US20250127756A1
Human necessities

COMPOSITIONS COMPRISING MDMA AND METHODS OF USING SAME

#689
US20250127757A1
Human necessities

COMPOSITIONS COMPRISING MDMA AND METHODS OF USING SAME

#690
US20250127758A1
Human necessities

USE OF CARBAMATE COMPOUND FOR PREVENTING, ALLEVIATING OR TREATING MYOTONIA

#691
US20250127759A1
Human necessities

METHODS AND DOSING REGIMENS COMPRISING A CDK2 INHIBITOR FOR THE TREATMENT OF CANCER

#692
US20250127760A1
Human necessities

COMPOSITION AND USE THEREOF IN PREPARATION OF MEDICAMENT FOR TREATING PRESBYOPIA

#693
US20250127761A1
Human necessities

Telmisartan Nanosuspension for Therapy of Respiratory Infections and Methods of Making and Using Same

#694
US20250127762A1
Human necessities

ISOXAZOLINE PARASITICIDE FORMULATIONS AND METHODS FOR TREATING BLEPHARITIS

#695
US20250127763A1
Human necessities

FORMULATION OF A RILUZOLE SOLUTION WITH BETA-CYCLODEXTRINS

#696
US20250127764A1
Human necessities

COMBINATIONS OF BETA-LACTAM COMPOUNDS AND PROBENECID AND USES THEREOF

#697
US20250127765A1
Human necessities

RAPID INDUCTION WITH MONTHLY INJECTABLE BUPRENORPHINE EXTENDED-RELEASE

#698
US20250127766A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING CDKL5 DISORDER USING MONOAMINE OXIDASE INHIBITORS

#699
US20250127767A1
Human necessities

Roflumilast Formulations with an Improved Pharmacokinetic Profile

#700
US20250127768A1
Human necessities

THERAPEUTIC TARGETING OF INOSITOL PYROPHOSPHATE SYNTHESIS IN CANCER

#701
US20250127769A1
Human necessities

ANTI-TUMOR PHARMACEUTICAL COMPOSITION BASED ON IMMUNE CHECKPOINT BLOCKADE AND USE THEREOF

#702
US20250127770A1
Human necessities

FORMULATIONS OF RADIPRODIL

#703
US20250127771A1
Human necessities

METHODS OF DIAGNOSING AND TREATING TOURETTE SYNDROME

#704
US20250127772A1
Human necessities

SPECIFIC TETRADENTATE COPPER CHELATORS FOR THE TREATMENT OF WILSON'S DISEASE

#705
US20250127773A1
Human necessities

MODULATORS OF THE BETA-3 ADRENERGIC RECEPTOR USEFUL FOR THE TREATMENT OR PREVENTION OF HEART FAILURE

#706
US20250127774A1
Human necessities

COMPOUNDS FOR LABELLING NUCLEIC ACID AND USES THEREOF

#707
US20250127775A1
Human necessities

METHOD OF INDUCING DENDRITIC AND SYNAPTIC GENESIS IN NEURODEGENERATIVE CHRONIC DISEASES

#708
US20250127776A1
Human necessities

ORAL PHARMACEUTICAL COMPOSITION

#709
US20250127777A1
Human necessities

DUAL INHIBITION OF MDM2 AND EIF2-ALPHA INDUCES CELL DEATH IN MULTIPLE CANCER CELL TYPES

#710
US20250127778A1
Human necessities

CANCER IMMUNOTHERAPY COMPOSITION CONTAINING INTERACTION INHIBITOR OF STING AND TRIM29 AS ACTIVE INGREDIENT

#711
US20250127779A1
Human necessities

METHODS OF TREATING ACUTE DEPRESSION AND ANXIETY

#712
US20250127780A1
Human necessities

IMIDAZO[4,5-B]PYRIDINE AND PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVES AS SIK MODULATORS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS

#713
US20250127781A1
Human necessities

USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)

#714
US20250127782A1
Human necessities

METHODS OF TREATING CANCER

#715
US20250127783A1
Human necessities

INHIBITORS OF THE PEPTIDYL-PROLYL CIS/TRANS ISOMERASE (PIN1), COMBINATIONS AND USES THEREOF

#716
US20250127784A1
Human necessities

Treatment of Telangiectasia

#717
US20250127785A1
Human necessities

Ribociclib Tablet

#718
US20250127786A1
Human necessities

Compositions and Methods for the Prevention and Treatment of Hearing Loss

#719
US20250127787A1
Human necessities

METHODS FOR TREATING PERIPHERAL NEUROPATHY

#720
US20250127788A1
Human necessities

PHARMACEUTICAL COMPOSITION CONTAINING TRIAZINE DERIVATIVE

#721
US20250127789A1
Human necessities

COMPOSITIONS USEFUL FOR MODULATING SPLICING

#722
US20250127790A1
Human necessities

COMBINATION THERAPY USING VPS34 INHIBITORS

#723
US20250127791A1
Human necessities

TRIPLE-AGENT THERAPY FOR CANCER TREATMENT

#724
US20250127792A1
Human necessities

IMIDAZOPIPERAZINE INHIBITORS OF TRANSCRIPTION ACTIVATING PROTEINS

#725
US20250127793A1
Human necessities

CONJUGATES OF SURROGATE LIGHT CHAIN CONSTRUCTS

#726
US20250127794A1
Human necessities

THERAPEUTIC THIAZINE DYE COMPOSITIONS AND METHODS OF USE

#727
US20250127795A1
Human necessities

Fused Pentacyclic Imidazole Derivatives as Modulators of TNF Activity

#728
US20250127796A1
Human necessities

METHODS OF TREATING CANCER WITH PI3K INHIBITOR, GDC-0077

#729
US20250127797A1
Human necessities

PRODRUG COMPRISING A DRUG-LINKER CONJUGATE

#730
US20250127798A1
Human necessities

METHODS FOR THE TREATMENT OF TINNITUS

#731
US20250127799A1
Human necessities

DRUG CONJUGATES FOR BONE MARROW PROTECTION

#732
US20250127800A1
Human necessities

PYRIMIDINE OR PYRIDINE DERIVATIVE AND MEDICINAL USE THEREOF

#733
US20250127801A1
Human necessities

BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND USES THEREOF

#734
US20250127802A1
Human necessities

HALIDE-FREE AMMONIUM SILANES

#735
US20250127803A1
Human necessities

2'-FUCOSYLLACTOSE AND LACTO-N-NEOTETRAOSE FOR PREVENTING AND TREATING OVERWEIGHT

#736
US20250127804A1
Human necessities

RIBOSE LINKERS AND CONJUGATES THEREOF

#737
US20250127805A1
Human necessities

ALCOHOLIC FORMULATION WITH A MIXTURE OF ALKALOIDS, PRENOL LIPIDS AND FLAVONOIDS

#738
US20250127806A1
Human necessities

INJECTABLE LIQUID PHARMACEUTICAL COMPOSITION CONTAINING GEMCITABINE AND A CYTIDINE DEAMINASE INHIBITOR

#739
US20250127807A1
Human necessities

TREATMENT OF VAGINAL DYSBIOTIC CONDITIONS WITH ASSOCIATED ELEVATED VAGINAL CALPROTECTIN

#740
US20250127808A1
Human necessities

METHOD FOR TREATING PERIODONTAL DISEASE

#741
US20250127809A1
Human necessities

COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES

#742
US20250127810A1
Human necessities

METHOD AND APPARATUS FOR PREPARING PLASMA ENRICHED IN IL-1RA

#743
US20250127811A1
Human necessities

MODULATION OF TGF BETA SIGNALING IN GENETICALLY-MODIFIED EUKARYOTIC CELLS

#744
US20250127812A1
Human necessities

COMPOSITIONS AND METHODS FOR ENGINEERING STABLE TREGS

#745
US20250127813A1
Human necessities

COMBINATION DRUG

#746
US20250127814A1
Human necessities

BOREALIN TARGETING POLYPEPTIDES FOR DETECTION AND TREATMENT OF CANCER

#747
US20250127815A1
Human necessities

BISPECIFIC CHIMERIC ANTIGEN RECEPTORS TARGETING CD20 AND BCMA

#748
US20250127816A1
Human necessities

SYSTEMS AND METHODS FOR GROWING MITOCHONDRIA AND COATING THEREOF

#749
US20250127817A1
Human necessities

APPLICATION OF BMSC-EXOS IN TREATING PD

#750
US20250127818A1
Human necessities

COMPANION METHODS AND KITS FOR IL-2-BASED THERAPIES AND MESENCHYMAL STEM CELL-BASED THERAPIES

#751
US20250127819A1
Human necessities

MSC-NTF SPECIFIC EXOSOMES AND USE THEREOF

#752
US20250127820A1
Human necessities

GENETICALLY MODIFIED CELLS FOR ALLOGENEIC CELL THERAPY TO REDUCE INSTANT BLOOD MEDIATED INFLAMMATORY REACTIONS

#753
US20250127821A1
Human necessities

PHARMACEUTICAL COMPOSITION AND COSMETIC COMPOSITION

#754
US20250127822A1
Human necessities

TOPICAL COMPOSITION COMPRISED OF COD LIVER OIL FOR TREATING WOUNDS AND SKIN DISORDERS

#755
US20250127823A1
Human necessities

COMPOSITIONS AND METHODS OF AFFECTING CYTOKINE LEVELS USING PREVOTELLA HISTICOLA

#756
US20250127824A1
Human necessities

BACTERIAL STRAIN USED IN THE PREVENTION AND/OR TREATMENT OF INFLAMMATORY PATHOLOGIES

#757
US20250127825A1
Human necessities

PROBIOTIC COMPOSITIONS AND METHODS OF USE THEREOF FOR WEIGHT LOSS

#758
US20250127826A1
Human necessities

Engineered Probiotics for Colorectal Cancer Screening, Prevention, and Treatment

#759
US20250127827A1
Human necessities

Probiotic Formulations for Improving Athletic Performance

#760
US20250127828A1
Human necessities

BACILLUS VELEZENSIS STRAINS AND COMPOSITION FOR PREVENTING, TREATING, OR IMPROVING TUBERCULOSIS COMPRISING THE SAME

#761
US20250127829A1
Human necessities

METHOD FOR PREVENTING AND/OR REPAIRING OCULAR CELL DAMAGE BY USING STREPTOCOCCUS THERMOPHILUS STRAIN AND ITS METABOLITES

#762
US20250127830A1
Human necessities

MICROORGANISM AND COMPOSITION COMPRISING SAME

#763
US20250127831A1
Human necessities

STRAIN OF LACTICASEIBACILLUS PARACASEI CAPABLE OF RELIEVING HYPERSENSITIVE RHINITIS AND APPLICATION THEREOF

#764
US20250127832A1
Human necessities

Lactobacillus Plantarum and Application Thereof in Production of Urolithin A

#765
US20250127833A1
Human necessities

TREATMENT OF WHITE FECES SYNDROME IN SHRIMP

#766
US20250127834A1
Human necessities

PLANT-DERIVED COMPOSITIONS THAT MODULATE CELLULAR IMMUNITY

#767
US20250127835A1
Human necessities

COMPOSITION BASED ON PLANT EXTRACTS AND USE THEREOF FOR THE PREVENTION AND/OR TREATMENT OF CARBOHYDRATE AND LIPID DYSMETABOLISM

#768
US20250127836A1
Human necessities

COMPOSITION FOR TREATMENT OF TOPICAL DERMATOLOGICAL BACTERIAL SKIN CONDITIONS

#769
US20250127837A1
Human necessities

FERMENTED TRADITIONAL CHINESE MEDICINE COMPOSITE PREPARATION FOR PREVENTING AND TREATING PIGLET VIRAL DIARRHEA, PREPARATION METHOD AND APPLICATION

#770
US20250127838A1
Human necessities

DUAL ACTING POLYMERS IN AN OSMOTIC FILM FOR TOPICAL APPLICATION TO TREAT INFLAMMATORY DISEASES AND CYTOKINE RELEASE SYNDROME

#771
US20250127839A1
Human necessities

METHOD TO INCREASE THE CONCENTRATION OF SHATAVARIN I AND SHATAVARIN IV IN EXTRACT FROM ROOTS

#772
US20250127840A1
Human necessities

METHOD FOR ACTIVATING DENDRITIC CELLS AND METHOD FOR ACTIVATING NATURAL KILLER CELLS, HELPER T CELLS, KILLER T CELLS, B CELLS, OR MACROPHAGES

#773
US20250127841A1
Human necessities

AGENT FOR IMPROVING INTESTINAL BACTERIA

#774
US20250127842A1
Human necessities

IMMUNE CHECKPOINT TARGETING THERAPEUTIC NANOPARTICLES

#775
US20250127843A1
Human necessities

ADRENOCORTICOTROPIC HORMONE PEPTIDE COMPOSITIONS AND METHODS OF USE

#776
US20250127844A1
Human necessities

PEPTIDE HAVING HAIR LOSS PREVENTION OR HAIR GROWTH PROMOTION ACTIVITY AND USE THEREOF

#777
US20250127845A1
Human necessities

MEDICINAL USES OF OLIGOPEPTIDES IN COMBINATION WITH AN ANTIANDROGEN

#778
US20250127846A1
Human necessities

DAPTOMYCIN FORMULATIONS

#779
US20250127847A1
Human necessities

Antigenic Epstein Barr Virus Polypeptides

#780
US20250127848A1
Human necessities

COMPOSITIONS FOR TREATING AUTOIMMUNE ARTHRITIS

#781
US20250127849A1
Human necessities

ATF5 Peptide Variants and Uses Thereof

#782
US20250127850A1
Human necessities

METHODS AND COMPOSITIONS FOR INHIBITING FIBROSIS AND SCARRING

#783
US20250127851A1
Human necessities

CYTOKINE MODULATION

#784
US20250127852A1
Human necessities

POLYPEPTIDES FOR TREATMENT OF CANCER

#785
US20250127853A1
Human necessities

METHODS AND COMPOSITIONS FOR REDUCING NEUTROPHILS OR NEUTROPHIL INFILTRATION AT THE SITE OF DISEASE

#786
US20250127854A1
Human necessities

A GENE THERAPY STRATEGY TO RESTORE ELECTRICAL AND CARDIAC FUNCTION, AND CARDIAC STRUCTURE, IN ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY

#787
US20250127855A1
Human necessities

Combination Therapy for CMML and MDS

#788
US20250127856A1
Human necessities

COMBINED PREPARATIONS FOR THE TREATMENT OF CANCER

#789
US20250127857A1
Human necessities

A COMPOSITION COMPRISING IL-36 AND/OR IL-18 FOR USE IN TREATING OCULAR DISORDERS

#790
US20250127858A1
Human necessities

NOVEL CYTOKINE PRODRUGS

#791
US20250127859A1
Human necessities

CNP PRODRUGS WITH LARGE CARRIER MOIETIES

#792
US20250127860A1
Human necessities

SEMAGLUTIDE DEPOT SYSTEMS AND USE THEREOF

#793
US20250127861A1
Human necessities

INSULIN FORMULATIONS AND USES IN INFUSION DEVICES

#794
US20250127862A1
Human necessities

TISSUE MATRIX MATERIALS AND ENZYMATIC ADHESIVES

#795
US20250127863A1
Human necessities

ANTIMICROBIAL PEPTIDE FOR ONYCHOMYCOSIS

#796
US20250127864A1
Human necessities

SMALL EXTRACELLULAR VESICLES EXPRESSING A DOMINANT NEGATIVE AMPK ALPHA 1 MUTANT FOR USE IN THE TREATMENT OF OBESITY

#797
US20250127865A1
Human necessities

Hyaluronidase Enzyme Formulations for High Volume Administration

#798
US20250127866A1
Human necessities

Hyaluronidase Enzyme Formulations for High Volume Administration

#799
US20250127867A1
Human necessities

METHOD OF TREATING PRECLINICIAL ALZHEIMER'S DISEASE

#800
US20250127868A1
Human necessities

HYPERACTIVATING LIPID NANOPARTICLES

#801
US20250127869A1
Human necessities

Tuberculosis Antigen Cassettes

#802
US20250127870A1
Human necessities

mRNA Vaccines Against Hantavirus

#803
US20250127871A1
Human necessities

METHODS AND COMPOSITIONS FOR RECOMBINANT DENGUE VIRUSES FOR VACCINE AND DIAGNOSTIC DEVELOPMENT

#804
US20250127872A1
Human necessities

RECOMBINANT LIVE ATTENUATED RSV VACCINE STRAIN AND PRODUCTION METHOD THEREFOR

#805
US20250127873A1
Human necessities

COMPOSITIONS AND METHODS FOR PREVENTION OF PISCINE MYOCARDITIS

#806
US20250127874A1
Human necessities

CMV EPITOPES

#807
US20250127875A1
Human necessities

LARGE-SCALE FLAVIVIRAL VACCINE PRODUCTION AND MANUFACTURE

#808
US20250127876A1
Human necessities

PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE VIRUS

#809
US20250127877A1
Human necessities

NOVEL IMMUNOGENS FOR INFLUENZA VIRUS VACCINES

#810
US20250127878A1
Human necessities

Rapid Acting Vaccine Against Nipah Virus

#811
US20250127879A1
Human necessities

NEWCASTLE DISEASE VIRUSES AND USES THEREOF

#812
US20250127880A1
Human necessities

FUSION POLYPEPTIDE

#813
US20250127881A1
Human necessities

An Immunogenic Composition of Disease-Associated Antigens for Use in a Vaccine, Antibody Production and Immunodiagnostic Tests

#814
US20250127882A1
Human necessities

NUCLEIC ACID-LIPID NANOPARTICLE AND METHOD USING THE SAME

#815
US20250127883A1
Human necessities

METHOD FOR INHIBITING ZOPHOBAS MORIO BLACK WASTING DISEASE

#816
US20250127884A1
Human necessities

Novel Epstein Barr Virus Immunotherapies

#817
US20250127885A1
Human necessities

ENGINEERED FC DOMAINS AND ENGINEERED HCMV VIRAL FC RECEPTORS

#818
US20250127886A1
Human necessities

ASSESSMENT AND TREATMENT OF CHRONIC HEPATITIS B

#819
US20250127887A1
Human necessities

Self-Assembling Nanoparticles Based On Amphiphilic Peptides

#820
US20250127888A1
Human necessities

Immunogenic Fusion Peptides Including FC Fragment and a Non Toxic B Subunit of AB5 Toxin

#821
US20250127889A1
Human necessities

IMMUNOSTIMULATORY COMPOSITION

#822
US20250127890A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING CORONAVIRUS INFECTIOUS DISEASE-19 (COVID-19)

#823
US20250127891A1
Human necessities

TREATMENT OF AUTOIMMUNE ENCEPHALITIS WITH SATRALIZUMAB

#824
US20250127892A1
Human necessities

DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) AND ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS)

#825
US20250127893A1
Human necessities

EGFR TARGETED THERAPY

#826
US20250127894A1
Human necessities

PROCESS FOR PRODUCING ARMED IMMUNE CELLS

#827
US20250127895A1
Human necessities

MODIFIED TUMOR INFILTRATING LYMPHOCYTE AND USE THEREOF

#828
US20250127896A1
Human necessities

CHIMERIC TIM4 RECEPTORS AND USES THEREOF

#829
US20250127897A1
Human necessities

NATURAL KILLER T-CELLS AND METHODS OF USING THE SAME

#830
US20250127898A1
Human necessities

PHOTODYNAMIC THERAPY AND DIAGNOSIS

#831
US20250127899A1
Human necessities

POTASSIUM-SODIUM TARTRATE AS GRANULATING AID

#832
US20250127900A1
Human necessities

STABLE PHARMACEUTICAL COMPOSITIONS

#833
US20250127901A1
Human necessities

BIODEGRADABLE POLYMER-OIL BLENDS AND USES THEREOF

#834
US20250127902A1
Human necessities

POLYMER-CARGO COMPOSITIONS AND METHODS

#835
US20250127903A1
Human necessities

SUBSTITUTED PIPERIDINE DEGRONIMERS FOR TARGET PROTEIN DEGRADATION

#836
US20250127904A1
Human necessities

SIGLEC LIGANDS, CONJUGATES, AND METHODS OF USE THEREOF

#837
US20250127905A1
Human necessities

GLUTARIMIDE COMPOUND AND USE THEREOF

#838
US20250127906A1
Human necessities

SMALL-MOLECULE DEGRADERS OF CDK8 AND CDK19

#839
US20250127907A1
Human necessities

PARP INHIBITORS

#840
US20250127908A1
Human necessities

HETEROBIFUNCTIONAL CONDITIONAL INHIBITORS

#841
US20250127909A1
Human necessities

Compositions, Systems, and Methods for Modulating a Target Gene

#842
US20250127910A1
Human necessities

PROGRAMMABLE POLYMERIC DRUGS

#843
US20250127911A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATMENT OF WOUNDS AND INFLAMMATORY SKIN CONDITIONS

#844
US20250127912A1
Human necessities

COMPOSITIONS FOR DELIVERY OF POLYNUCLEOTIDES

#845
US20250127913A1
Human necessities

BIFUNCTIONAL FOLATE RECEPTOR BINDING COMPOUNDS

#846
US20250127914A1
Human necessities

ANTIBODY-CONJUGATED 8-SULFONYL-BENZAZEPINE COMPOUNDS AND THEIR USES

#847
US20250127915A1
Human necessities

ANTI-CLDN-18.2 ANTIBODY-DRUG CONJUGATE AND USE THEREOF

#848
US20250127916A1
Human necessities

ANTIBODY DRUG CONJUGATE (ADC) TARGETING NECTIN 4 AND COMPRISING AN EXATECAN PAYLOAD

#849
US20250127917A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING CANCERS

#850
US20250127918A1
Human necessities

SITE-SELECTIVE CONJUGATION OF A PHARMACEUTICAL AGENT TO AN ANTIBODY USING AN AFFINITY PEPTIDE

#851
US20250127919A1
Human necessities

METHODS OF LOADING EXTRACELLULAR VESICLES

#852
US20250127920A1
Human necessities

GAMMA-D POLYGLUTAMATED ANTIFOLATES AND USES THEREOF

#853
US20250127921A1
Human necessities

PH-RESPONSIVE NANO PARTICLE FOR DELIVERY OF RIBONUCLEOPROTEINS

#854
US20250127922A1
Human necessities

CAPSID

#855
US20250127923A1
Human necessities

Isolated modified capsid protein VP1 from adeno-associated virus serotype 5 (AAV5), capsid and vector based thereon

#856
US20250127924A1
Human necessities

GENE EDITING SYSTEMS COMPRISING AN RNA GUIDE TARGETING STATHMIN 2 (STMN2) AND USES THEREOF

#857
US20250127925A1
Human necessities

DUALLY DERIVATIZED CHITOSAN NANOPARTICLES AND METHODS OF MAKING AND USING THE SAME FOR GENE TRANSFER IN VIVO

#858
US20250127926A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING SENSORINEURAL HEARING LOSS USING OTOFERLIN DUAL VECTOR SYSTEMS

#859
US20250127927A1
Human necessities

TARGETED INTEGRATION AT BETA-GLOBIN LOCUS IN HUMAN HEMATOPOIETIC STEM AND PROGENITOR CELLS

#860
US20250127928A1
Human necessities

GJB2 REGULATORY ELEMENTS AND USES THEREOF

#861
US20250127929A1
Human necessities

SCAFFOLDS FOR MODIFYING IMMUNE CELLS AND THE USES THEREOF

#862
US20250127930A1
Human necessities

HYBRID REGULATORY ELEMENTS

#863
US20250127931A1
Human necessities

NOVEL IMMUNOSTIMULATING VECTOR SYSTEM

#864
US20250127932A1
Human necessities

METHOD FOR DELIVERING RNA TO NEURONS TO TREAT HERPES INFECTIONS

#865
US20250127933A1
Human necessities

Method of verifying effectiveness and stability of linker in Drug Delivery system and Structure therefor

#866
US20250127934A1
Human necessities

HIGH-BRIGHTNESS FLUOROPHORES

#867
US20250127935A1
Human necessities

PSMA LIGAND TARGETED COMPOUNDS AND USES THEREOF

#868
US20250127936A1
Human necessities

Contrast agent for magnetic resonance imaging

#869
US20250127937A1
Human necessities

FAP INHIBITOR

#870
US20250127938A1
Human necessities

THERAGNOSTIC FOLATE CONJUGATES

#871
US20250127939A1
Human necessities

COMPOUNDS FOR POSITRON EMISSION TOMOGRAPHY

#872
US20250127940A1
Human necessities

RADIOPHARMACEUTICAL AND METHODS

#873
US20250127941A1
Human necessities

DETECTION AND LOCALIZATION OF INTERNAL BLEEDING

#874 ✅ Patent 12,364,777 granted on 2025-07-22
US20250127942A1
Human necessities

HOMODIMERIC ANTIBODIES FOR USE IN TREATING CANCERS AND METHODS OF USE

#875
US20250127943A1
Human necessities

METHODS AND COMPOSITIONS FOR TARGETING DISEASE RELATED CELL SURFACE RECEPTORS USING RADIOLABELED AND/OR CYTOTOXIN LABELLED ANTIBODIES

#876
US20250127944A1
Human necessities

HYDROXYL GENERATOR HOUSING WITH MODULAR COMPONENTS

#877
US20250127945A1
Human necessities

UV-B LIGHT GENERATING SYSTEM

#878
US20250127946A1
Human necessities

Disinfecting Locker

#879
US20250127947A1
Human necessities

DEVICE FOR VERIFICATION OF BIOLOGICAL INDICATORS IN A STERILISATION OR DECONTAMINATION CHAMBER FOR PRODUCTION

#880
US20250127948A1
Human necessities

SWITCHABLE GAS AND LIQUID RELEASE AND DELIVERY DEVICES, SYSTEMS, AND METHODS

#881
US20250127949A1
Human necessities

AEROSOL SPRAYS, METHODS OF GENERATING AEROSOL SPRAYS, AND AEROSOL DISPENSING SYSTEMS

#882
US20250127950A1
Human necessities

Air Conditioning Disinfection and Sterilization Device

#883
US20250127951A1
Human necessities

SILICA GEL FOAM DRESSING

#884
US20250127952A1
Human necessities

POLYMERIC MATRIX FOR HAEMOSTATIC APPLICATION AND THERAPEUTIC BANDAGE THEREOF

#885
US20250127953A1
Human necessities

INTRAOPERATIVE USES OF SETTABLE SURGICAL COMPOSITIONS

#886
US20250127954A1
Human necessities

THREE-DIMENSIONAL NETWORK AQUEOUS GEL AND MANUFACTURING METHOD THEREOF

#887
US20250127955A1
Human necessities

MIXED SOLVENT HYDROGEL SYSTEM FOR WOUND HEALING

#888
US20250127956A1
Human necessities

A PLA-COLLAGEN SCAFFOLD FOR MEDICAL USE LOADED WITH CELLS

#889
US20250127957A1
Human necessities

ADDITIVE MANUFACTURING METHOD FOR PRODUCING BIO-MIMETIC NANOCOMPOSITE SCAFFOLD

#890
US20250127958A1
Human necessities

DERMAL FILLERS AND APPLICATIONS THEREOF

#891
US20250127959A1
Human necessities

METHODS TO INHIBIT OSTEOPOROSIS THROUGH IMPLANTATION

#892
US20250127960A1
Human necessities

Magneto-Patterned-Cell-Laden Hydrogel Materials and Methods of Making and Using Same

#893
US20250127961A1
Human necessities

BONE REGENERATION MATERIAL, METHOD FOR MANUFACTURING BONE REGENERATION MATERIAL, AND BONE REGENERATION MATERIAL MANUFACTURING DEVICE

#894
US20250127962A1
Human necessities

GEL COMPRISING A HYDROGEL AND FAT OR A FAT DERIVATIVE IN THE FORM OF AN EMULSION

#895
US20250127963A1
Human necessities

INJECTABLE ANTI-HEART FAILURE HYDROGEL WITH MYOCARDIAL TISSUE REPAIR FUNCTION, PREPARATION METHOD AND USE THEREOF

#896
US20250127964A1
Human necessities

SYSTEMS AND METHODS FOR GEL-BASED NEUROMODULATION

#897
US20250127965A1
Human necessities

Tissue Regeneration Particles with a Controlled Structure

#898
US20250127966A1
Human necessities

MILK BOWL AND WEARABLE BREAST PUMP

#899
US20250127967A1
Human necessities

BREAST PUMP BODY AND BREAST PUMP

#900
US20250127968A1
Human necessities

BREAST PUMPS